Table 1.
Inclusion and exclusion criteria.
Fig 1.
(A) Each area of the modified ETDRS grid was showed. (B) As examples, three colors below were displayed. Yellow; Macula, Superior. Green; Parafovea, Lateral/Nasal. Blue; Fovea, Inferior.
Fig 2.
There are MAs in each the modified ETDRS grid areas. Red arrows indicate MAs.
Fig 3.
Patients were included in this clinical study, all of whom received ranibizumab IVT.
Table 2.
Characteristics.
Table 3.
Detected MA by FA.
Table 4.
Detected MA by IA.
Table 5.
Detected MA by OCTA.
Fig 4.
Detected MA of a non-responder case.
68-years-old male. There was a large MA (red allow) surrounded blockings by hard exudates in nasal macula area. IA and FA could detect the MA; OCTA could not detect.
Fig 5.
Detected MA of a responder case.
67-years-old female. There was less MAs in nasal area in spite of many MAs in superior and inferior area. Not only FA and OCTA but also IA could not detect noticeable MAs in nasal area.